Benjamin Hickey Bristol Myers Squibb CO (BMY) insider trading activity

BMY Quotes by TradingView

Benjamin Hickey is President, RayzeBio Org. of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 7,133 shares of BMY, which is worth approximately $396,095. The most recent transaction as insider was on Feb 01, 2025, when has been sold 3,725 shares (Common Stock, $0.10 par value) at a price of $58.95 per share, resulting in proceeds of $219,588. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.13K
n/a 3M change
n/a 12M change
Total Value Held $396,095

Benjamin Hickey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2025
SELL
Payment of exercise price or tax liability
$219,588 $58.95 p/Share
3,725 Reduced 34.31%
7,133 Common Stock, $0.10 pa...
Feb 01 2025
BUY
Exercise of conversion of derivative security
-
10,078 Added 48.14%
10,858 Common Stock, $0.10 pa...

Also insider at

MRTX
Mirati Therapeutics, Inc. Healthcare
EVP, Chief Commercial Officer
SURF
Surface Oncology, Inc. Healthcare
Director
MURA
Mural Oncology plc
BH

Benjamin Hickey

President, RayzeBio Org.
San Diego, CA

Track Institutional and Insider Activities on BMY

Follow BRISTOL MYERS SQUIBB CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

News

Receive news related to BRISTOL MYERS SQUIBB CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BMY